InsiderTrades

Form 4 for VIR Vir Biotechnology, Inc.

Accepted 2024-10-24 00:00:00 ET · period of report 2024-10-23 · accession 0001628280-24-043632 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2024-10-24 2024-10-23 VIR SCANGOS GEORGE A Dir J - Other $0.00 -598.3K 598.3K -50% $0
2024-10-24 2024-10-23 VIR SCANGOS GEORGE A Dir J - Other $0.00 +598.3K 719.3K +494% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-10-23 J D 598,270 $0.00 1,151,730 I See footnote — — (F3) The shares are held by the spouse of the reporting person.
2 Common Common Stock 2024-10-23 J D 598,270 $0.00 1,151,730 I — —
3 Common Common Stock 2024-10-23 J A 598,270 $0.00 719,259 D See footnote — — (F2) The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
4 Common Common Stock 2024-10-23 J A 598,270 $0.00 598,270 I See footnote — — (F4) The shares are held in the name of Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.